Joseph Elliot, Ph.D., President & CEO
P: 416-673-8153
E:
jelliot@receptor.ca www.receptor.ca Receptor Therapeutics Inc. is a green-field start-up company seeking to in-license two or three late pre-clinical or early clinical development candidates in oncology or infectious disease. Receptor has assembled a seasoned management, experienced Board and an outstanding team of drug development advisors to direct its programs. The Company is supported by deep-pocketed venture capital investors. Receptor is seeking opportunities that can be rapidly developed to the next level of value.